Author: sgwealthbuilder

Lifetime Membership The past few days had been absolutely chaotic as global stock markets tumbled over fear of recession and soaring inflation in US. Investors were bracing for US Federal Reserves to raise interest rate hikes aggressively to fight the raging inflation. Consequently, the Federal Reserves did raise interest rate – by a whopping 75 basis points, the biggest hike since 1994. Will OCBC share price rocket in the aftermath of the interest rate hike?

Conventional wisdom indicates that bank stocks should perform well in high inflationary environment as high interest rates generally lead to higher net interest incomes for the banks. This was my hypothesis when I invested in 6000 of OCBC shares in August 2021. Back then, I anticipated that US Federal Reserves would hike interest rates this year and that Singapore bank stocks would be the biggest beneficiary from the rate hikes. However, OCBC share price flatter to deceive. And I was humbled.

Till date, US Federal Reserves had raised interest rate by 150 basis points (75 basis points on 15 June, 50 basis points on 7 May and 25 basis points on 17 March). Yet, OCBC share price remained stagnant year-to-date (at the point of writing). The sluggish OCBC share price prompted me to sell when OCBC share price was trading at $12.40 in May 2022.

Lifetime Membership The power tailwind may turn out to be a deadly headwind. Many analysts, including myself, had believed that the ongoing US Federal Reserve interest rate hikes will turbocharge Singapore bank stocks like DBS Group Holdings share price to high heavens. Yet that fantasy has not materialized despite the fact that US Federal Reserves had raised interest rate by 75 basis points (50 basis points on 7 May and 25 basis points on 17 March). Year-to-date, DBS Group Holdings share price had tumbled 8% instead. What the hell has happened to the leading light of SGX?

A concerned SG Wealth Builder Lifetime member has written in to enquire about the bizarre performance of Singapore bank stocks against the backdrop of rising interest rates. To be fair, US bank stocks like Bank of America and JP Morgan have performed worse in comparison to their Singapore counterparts, falling by an average of 25% year-to-date.

The prevalent thinking is that the surging inflation, coupled with the rising interest rates, could tip global economy into a recession. It also doesn’t help that the ongoing Ukraine-Russia conflict worsens the global supply-chain disruption brought forth by the pandemic. All these uncertainties create fear in the market.

Lifetime Membership What a devastating plunge! From $13.06 on its first trading day (2 December 2021), Grab share price plunged by 80% to reach the abysmal level of $2.90. The terrifying nose-dive made Grab shares one of the worst IPO performers in recent memory, triggering plenty of soul-searching among investors.

Lately, one of my Lifetime Members wrote in to enquire about the disappointing performance of the “Super App” in Nasdaq. He also enquired if Grab should be listed in Southeast Asia instead of US. Indeed, much ink has been spilled on the volatility of Grab share price. I will attempt to cover the poor performance of Grab share price from another perspective.

When Grab debut in Nasdaq, data revealed that the short interest volume (29.4 million) had already exceeded the average daily share volume (26.7 million). To be frank, this is nothing out of ordinary. In the US market, short selling attacks are very prevalent. But what is intriguing is that the short interest for Grab surged consistently since IPO to reach more than 4-fold.

Based on the short interest data, it appears to me that the short-sellers have very bearish outlook for Grab share price. In fact, the volumes of short interest in the past six months are also not showing any signs of peaking.

Lifetime Membership When SPH shareholders approved the acquisition by Cuscaden Peak on 22 March 2022, the writing was on the wall that SPH REIT would be the next to be acquired. Indeed, the consortium subsequently announced the chain offer of SPH REIT at $0.9640 per unit on 29 April 2022. Should unitholders accept, reject or run for their lives?

Cuscaden Peak is a consortium that is made up of entities linked to Hotel Properties (40%), CapitaLand Group (30%) and Mapletree Investments (30%). Given that CapitaLand and Mapletree are majority-controlled by Temasek Holdings and are sponsors of S-REITs, what is the possibility of the assets of SPH REIT being injected into MPACT or CICT? In life, never say never. After all, the S-REIT sector is undergoing a wave of consolidation post-pandemic.

Before we talk about life after the chain offer, let’s take a look at the unfolding chain offer. It should be noted that after adjusting for the 1QFY2022 and 2QFY2022 distributions, the offer price is actually $0.9372 per unit. At the point of writing, SPH REIT unit price is being traded at $0.945. In this regard, some unitholders may feel that they were given a raw deal. One member of SG Wealth Builder even enquired if a delisting is on the cards.

Lifetime Membership Since the start of the year, stock market sentiments have been pretty much bearish. The US Federal interest rate hikes, combined with the Russia-Ukraine conflict, have created much uncertainties for the market. For this reason, it is not surprising that the unit price of Keppel DC REIT (SGX: AJBU) turned sluggish, falling by 17% year-to-date. Several members of SG Wealth Builder have written to express their concerns on the falling Keppel DC REIT unit price.

From $3.00 in January 2021 to the current $2.05, the correction in Keppel DC REIT unit price has lasted for more than a year. As the plunge started before the events unfolded in 2022, the drop is indeed puzzling. In this regard, unitholders have every reason to be concerned. Some of them are also wondering if it is worthwhile to continue holding the stock. Although I am not vested in this counter and could not advise members or readers on the course of actions for their investments, I would like to share my investment approach for S-REITs.

Currently, I am vested in another S-REIT, Mapletree Logistics Trust. I entered at $1.96 in last year. Like Keppel DC REIT, Mapletree Logistics Trust has been in a severe bout of correction mode since last year, falling by 11.7% year-to-date.

Being the top dog in the aviation industry, SIA (SGX: C6L) is one of the leading lights of SGX. As the world emerges from the ravages of the COVID-19 pandemic, how will SIA share price (SGX: C6L) unravel in the coming months? To make money from stocks, it is crucial to buy low and sell high. In that perspective, I would like to share my insights on whether the current SIA share price is a good entry point.

My last article on SIA share price (SGX: C6L) was on 6 February 2022. In that article, I predicted SIA share price to be trading between the $6 to $7 bandwidths in 2022. So far, the counter is still some way off the levels that I have forecasted. However, it should be noted that the article was written before the implosion of the Russian-Ukraine war, the US interest rate hikes and the COVID-19 lockdowns in China. Given the dramatic change in the operating climate, let’s take a look whether my original thesis still stands.

Chart: BullionStar

Due to the countless twists and turns of the pandemic saga, analysing the outlook of SIA share price is always a tricky business. But one thing I think I got it right is the close correlation of SIA share price with the oil price movements.

From hero to zero, Alibaba founder Jack Ma’s fall from grace has been nothing short of spectacular. In October 2020, Jack Ma, blasted Chinese financial regulators for stifling innovation at the Bund Summit in Shanghai. The criticism did not go down well with the Chinese authorities who subsequently launched a slew of regulatory crackdowns targeting Chinese tech stocks. Since then, Alibaba share price (HKEX: 9988) had endured a torrid run.

The collapse of Alibaba share price (HKEX: 9988) has caused plenty of heart pains for investors. Numerous investors had entered this counter when Alibaba share price (HKEX: 9988) was trading between HK$150 to HK$298. Given that Alibaba share price (HKEX: 9988) is currently trading at about HK$80 bandwidth, the rout had been pretty devastating for investors. The question now is whether recovery is in sight for Alibaba share price (HKEX: 9988).

Many investors had been buying on the dip – buying more shares as Alibaba share price (HKEX: 9988) continues to plunge. Although such strategy is not unsound, many investors are starting to panic as there is no sign of bottoming of share price. And what if the end-point for Alibaba share price (HKEX: 9988) is HK$1? That would be an absolute nightmare!

My last update on Mapletree Logistics Trust (MLT) unit price (SGX: M44U) was in January 2022. Since then, the counter went through some volatility, falling from $1.78 to a low of $1.69 in end of January 2022 and then surge to a high of $1.88 in early April before falling to the current $1.68. As a unitholder, the volatility of MLT unit price (SGX: M44U) is certainly unsettling, at least for me. What could be the reason for the trend of MLT unit price (SGX: M44U)?

For background, the principal activity of MLT is to invest in a diversified portfolio of logistics real estate in Asia Pacific with the aim of providing its unitholders with a stable distribution stream. As at 31 March 2022, the Group’s portfolio had grown to a portfolio of 183 properties, comprising 53 properties in Singapore, 9 in Hong Kong SAR, 42 in China, 19 in Japan, 19 in South Korea, 13 in Australia, 16 in Malaysia, 10 in Vietnam and 2 in India. The total value of assets under management is $13.1 billion.

The recent correction of MLT unit price (SGX: M44U) was partially attributed to the counter being ex-dividend on 9 May 2022. The S-REIT announced distribution per unit (DPU) of 2.268 cents for quarter ended 31 March 2022.

On 5^th of May 2022, Dow Jones crashed 1063 points amid concerns of recession and surging global inflations. The following day, the Straits Times Index (STI) suffered a rout. In the sea of red, the bullish form of AEM share price stood out. At one point, AEM share price surged 2.5%, making it the top gainer in SGX. However, by the end of the trading day, the counter surrendered all the gains and fizzled out.

The volatile form of AEM share price came on the back on a solid first quarter financial update for FY2022, which saw the semiconductor test equipment manufacturer posting its highest quarterly revenue and profit before tax in its history. Net profit rocketed more than three-fold to smash a high of $40.8 million while revenue hit $262 million.

Previously, I wrote that AEM may become a $1 billion revenue company. On the basis of the quarterly performance, that day will come sooner than I expect. In fact, I would have expected AEM share price to breeze past the $5.00 mark on 6^th May 2022. If not for the overall stock market carnage, the stellar first quarter performance would have turbocharged AEM share price to high heavens.

Is Xiaomi share price (HKEX: 1810) at a good entry level now? My last coverage on Chinese tech stocks (Alibaba HKEX: 9988) was in February 2021. Back then, Chinese tech stocks were embroiled in a slew of regulatory headwinds following Jack Ma’s epic criticism against the regulators’ stifling innovation of the financial system. That action triggered an unprecedented storm that saw aggressive regulatory clamp downs on Chinese tech stocks.

Obviously, nobody in his right mind would have predicted the storm to last for two years. During this period, it is understandable that many investors are depressed after seeing their investments evaporated with the meltdown of Chinese tech stocks. Against this backdrop, many investors must be praying fervently for light at end of the tunnel. Recently, an SG Wealth Builder Lifetime Member requested for the coverage on one of the Chinese tech stocks: Xiaomi share price (HKEX: 1810), which I will duly oblige.

Admittedly, I have not invested in foreign stocks before, much less Chinese tech stocks. However, I have been watching the unfolding of the rout of Chinese tech stocks for the past two years. Like many Chinese tech stocks, Xiaomi share price (HKEX: 1810) had suffered huge carnage due to the crisis of confidence in Chinese tech stocks.

At the request of an SG Wealth Builder Lifetime Member, I am covering EngGro share price in this article. With a market capitalization of just $157.9 million, this is a very small cap stock in SGX. Admittedly, prior to the request from my member, I have not heard of this company before. I believe I am not alone as this counter falls under the radar of many analysts. However, a closer look on this company reveals some interesting findings.

EnGro’s history dates back to 1973 when it was formed as a tri-partite joint venture among SsangYong Cement Industrial Co. Ltd (South Korea), DBS Bank, and Afro-Asia Shipping Co. Listed on the SGX main board since 1983, the company was previously known as SsangYong Cement (Singapore) Pte Ltd. However, SsangYong Cement exited the business in 2005 and the company was renamed as EnGro Corporation Limited.

As of 15 March 2022, the largest shareholder of EnGro is Dr Chua Thian Poh, Executive Chairman of Ho Bee Land, which controls Afro-Asia International Enterprises Pte Limited. Dr Chua holds 38.68% stake in EnGro. Ho Bee Land is known for being the developer of Sentosa Cove.

To be specific, EnGro is provider of building materials, specializing in specialty cement and high-performance concrete supply.

This will be my first coverage of Singtel share price in 2022. My last coverage on this counter was on 31 December 2021. Since then, Singtel share price has surged from $2.30 to $2.65 at the point of writing. Year-to-date, Singtel share price has increased about 14%. Is this yet another false dawn or light at end of tunnel for the leading regional telco?

Whilst it may be too early for investors to pop the champagne, the operating climate has certainly improved significantly as compared to 2021. The lifting of COVID-19 restrictions in March had pushed Singtel share price to an almost 2-year high as the incoming volume of tourists should increase revenue for the Singapore Consumer business. Nonetheless, the positive effect should kick in from the new financial year onwards (Singtel’s financial year ends on March).

The coming weeks should see plenty of volatility for Singtel share price as the telco will release its full-year financial result. Based on the results of the past three quarters, the full-year result should be stellar, thereby providing a tailwind for Singtel share price. To put the icing on the cake, Singapore announced further relaxation of public health measures on 22 April 2022. Arising from this, number of tourists should spike in the coming months, providing another catalyst driver for Singtel share price.

What a supersonic form! Investors must buckle their seat belts and brace for the wildest ride of their lives. AEM share price went on a rampage following a series of share purchases by its biggest shareholder – Temasek Holdings. Temasek’s entry in August 2021 saw the sovereign wealth fund taking an initial stake of 9.5% in AEM. Within six months, Temasek increased its stake to 12.08% following a slew of share purchases in 2022. What is the game plan that Temasek has in mind for AEM?

Whilst Temasek’s strategic investment in AEM may seem like a no-brainer, the narrative may not be so straightforward, at least for Temasek. To put things into perspective, Temasek used to have two major assets in the semiconductor industry – Chartered Semiconductor and Stats Chippac. Chartered Semiconductor used to be the world’s third largest chipmaker while Stats Chippac was the biggest Southeast Asia assembly and chip-testing company. Despite so, Temasek had disposed them during the previous downturn of the semiconductor industry.

Chartered Semiconductor was sold to Abu Dhabi in 2009 while Stats Chippac was sold to China’s JCET in 2015. Both companies were delisted from SGX following the buyouts. The rationale for Temasek to sell was understandable as both assets were struggling to turn around for years.

Should it be “Sell in May and Go Away” or “Sell in March and Go Away”? In recent years, crises seemed to occur in March, leading to severe stock market corrections. In March 2020, we had the explosive market routs caused by the pandemic. And then in March 2022, the Russian war in Ukraine sent global markets into a devastating tailspin. Being one of the major Straits Times Index (STI) components, OCBC share price saw plenty of volatility.

To be frank, the recent March correction for OCBC share price could have been even more severe if its not for the timely ease of pandemic measures announced on 25 March 2022. The relaxation of measures should bode well for local banks as the operating environment improves significantly in the coming month. Rightfully, as we enter endemic, Singapore economy should recover and grow. Being the bellwether of the economy, OCBC Bank is likely to see healthy growth, thereby stimulating OCBC share price. Nonetheless, things are often not so straightforward in life.

Inflation has thrown a spanner in the works for the recovery of global economy, which has barely emerged from the pandemic. And the Russia war has added even more fuel to the fire.

After surging from $1.00 in 2020 to an incredible high of $10 in 2021, how will iFAST share price unravel in 2022? The spell-binding run of iFAST share price was certainly stuff of legend among SGX stocks. Given that the counter has recently stalled at $6.00 levels, is it a good time for investors to enter?

For background, iFAST is basically an online platform company offering investment products to retail investors. At the same time, financial institutions and banks can distribute their investment products through iFAST’s platform. The supersonic boom of iFAST share price was due to the award of Hong Kong ePension scheme in early 2021. iFAST partnered with Hong Kong’s PCCW (owned by Li Ka Shing’s son Richard Li) to develop the digital platform for Hong Kong’s HK$1 trillion Mandatory Provident Fund.

According to the latest disclosure by iFAST, the ePension division is expected to be the biggest driver for revenue and profits from 2023. This means that the project should be operationalized by end 2022. From now till end 2022 is less than a year. Against this backdrop, there should be tremendous catalyst for iFAST share price to take off within these two years.

For perspective, the management shared in the latest financial guidance that the net revenue target from the Hong Kong division should be more than HK$800 million in 2024 and HK$1.2 billion in 2025.

Since my last coverage on Sembcorp Industries share price in June 2021, there was much volatility for this counter. The pandemic disaster in India had led to plenty of uncertainties for Sembcorp Industries’ India thermal projects, causing Sembcorp Industries to be bearish from June to October 2021. The litmus test arrived when the Group announced on 2 August 2021 the impairment of $212 million for its 49%- owned joint venture Chongqing Songzao Sembcorp Electric Power Co.

That announcement on 2 August 2021 caused Sembcorp Industries share price to tumble to a low of $1.80 in October 2021. Consequently, the management went on a rescue mission for Sembcorp Industries share price by embarking on a series of shares buybacks. As at 13 December 2021, the management repurchased 6,780,700 shares from the market. Based on the recent bullish run of Sembcorp Industries share price, it seems that the shares buybacks helped to revive the stock.

Since the fateful demerger of Sembcorp Industries with Sembcorp Marine, Sembcorp Industries share price had gone from strength to strength, surging from $1.18 in September 2020 to the recent $2.65. Within the span of just 1.5 year, Sembcorp Industries share price rocketed more than 100%. With the robust Sembcorp Industries share price, credit should be given to the Group CEO, Wong Kim Yin, who joined the Group only in July 2020.

Talk about being at the right time and right place! On 25 March, Singapore Prime Minister announced the ease of public health measures for the pandemic, thereby improving business sentiments for aviation, hospitality and F&B. The relaxation of measures should bode well for local banks due to the loan exposures to these sectors which had been hit by the pandemic. As the operating environment improved significantly, OCBC share price should enjoy some tailwinds in the coming months.

At the moment, OCBC share price should be at a turning point as the counter has largely factored in the Russia-Ukraine conflict and pandemic impacts. The series of interest rate hikes should be the key catalyst driving the share price upward. Is this a good opportunity to enter? I would say so if you have done your risk assessment and diversified your portfolio. Being the oldest bank in Singapore, this blue chip is an evergreen STI component that will withstand the test of time.

Looking back, the past two months had been an absolutely gut-wrenching ride for investors as OCBC share price plunged into chaos. The day of Russia’s ‘special military operation’ in Ukraine coincided with the release of OCBC’s full-year financial result for FY2021.

Amid the raging inflation and uncertainty inflicted by the ongoing Russia-Ukraine conflict, market sentiments had been gloomy in the past three months. And rightly so. After all, many analysts had previously predicted that 2022 could be the year of global recovery from the devastating pandemic. But the Russia-Ukraine conflict had emerged out of nowhere to torpedo global stock markets. Of course, DBS share price was not spared from the fallout.

Despite the chaos in the market, DBS share price appreciated 6.8% year-to-date. Looking back, DBS share price had been on a rather bullish form in the start of the year. Investors had bought into this counter with anticipation of a stellar full-year FY2021 result. And the bank delivered. Then again Man proposes, God disposes. Unexpectedly, Dow Jones fell 500 points on 11 February 2022 following news of a potential Russian-Ukraine conflict. In the aftermath, DBS share price had a minor correction.

Investors’ worst nightmare came true as the Russia’s “special military operation” in Ukraine unfolded. As a result, DBS share price tumbled from a high of $37.20 on 14 February to a low of $31.20 on 8 March, representing a correction of 16% within the span of three weeks. Yet the announcement of the much-anticipated 0.25% interest rate hike by the US Federal Reserve on 16 March had rescued DBS share price from the gallows.

The last time that I covered Boustead share price was in November 2016. Back then, the company was still struggling from the fallout due to the oil slump. Recently, a member of SG Wealth Builder requested for a coverage of Boustead share price, which I would duly oblige to do so.

Ten years ago, this counter had been on my watchlist as Boustead share price rose from $0.80 in January 2012 to an incredible high of $1.90 in April 2014. Back then, investors must have felt so surreal. By the time of my last coverage in November 2016, the bubble has burst for Boustead share price as the stock collapsed to the $0.80 bandwidth. The collapse of Boustead share price was largely due to the ailing oil and gas industry from 2014 to 2019.

During the initial onset of the pandemic in 2020, Boustead share price came under further pressure as the counter plummeted to a low of $0.60 in April 2020. That was the period when crude oil prices were being traded at negative levels. Fast forward to 2022, as we approached endemic, Boustead share price has somewhat recovered to $0.90. Having said that, retail investors’ interest in Boustead share price has cooled considerably.

The year 2022 turns out to be a terrifying year for investors. Barely emerging from the protracted pandemic, the world economy looks set for another tumultuous ride as Russia’s “special military operation” in Ukraine continues to rock global community. Against this backdrop, AEM share price spirals out of control. Will AEM share price rise from the ashes like a phoenix to fulfil its destiny to be a $1 billion revenue company?

AEM share price rockets with Temasek Holdings!

Despite the gloomy operating climate, it is too early to write off AEM share price. On 7 March 2022, Temasek Holdings increased its stake in AEM to 10.29% following the acquisition of 1.41 million shares for about $3.95. The shares acquisition by Temasek Holdings is deemed by many to be a vote of confidence on the outlook for AEM share price.

AEM share price was then given further boost on 8 March when there was a transaction of 3 million shares for its USD counter. The AEM USD counter had been under pressure lately due to the perceived lack of turnover. On hindsight, the move by the management to launch the USD counter is prudent as we can extrapolate how well AEM may perform if it is dual-listed in NASDAQ.

LIFETIME MEMBERSHIP The last time that I had covered Q&M share price was in 2019. That was really the land before time! Recently, a Lifetime Member requested for an update on this counter. If you would like me to provide my insights on SGX stocks, please do sign up as member here!

The coverage of Q&M share price is timely as I realized that the company recently managed to turn around from years of stagnant revenue and profit. COVID-19 imploded out of nowhere in 2020 and the company rode on the wave to stage an impressive recovery. But what truly got me excited was Q&M’s stunning announcement in January 2022 to explore a proposed listing of Acumen Diagnostics on the NASDAQ stock exchange.

Acumen Diagnostics is a joint venture of Q&M Dental and it researches, manufactures, sells and distributes COVID-19 diagnostic test kits, as well as provides COVID19 testing services. Question now is: what is the kind of impact that a NASDAQ listing would bring for Q&M share price?

It seems that Q&M Dental has hit the jackpot with Acumen Diagnostics. Q&M Dental recorded a record revenue and profit for FY2021 as gross profit for the COVID-19 medical laboratories rocketed nearly 20-fold from last year to hit $22.3 million.

LIFETIME MEMBERSHIP On 24 February, Russia sent global markets into a devastating turmoil following the full-scale invasion on Ukraine. Yet on that fateful day, Global Testing share price stunned Singapore stock market when it took off like a rocket, surging an eye-popping 130% within a week to hit a high of $1.42. The incredible surge of Global Testing share price confounded many investors. Due to this, a Lifetime Member has requested a coverage on this interesting counter.

For background, Global Testing provides testing services such as wafer sorting and final testing for mixed-signal and logic integrated circuits to the semiconductor industry. Its testing services include test program development and conversion. In addition, they also help their customers to convert single-site testing to multi-site testing to shorter their turn around time. Being listed in SGX, the company’s main testing facilities are based in Taiwan. Its customers include Taiwan Semiconductor Manufacturing Company Limited (TSMC) and United Microelectronics Corporation (UMC).

Although Global Testing has been listed in SGX Mainboard since 2005, the market capitalization is very small – at about $43 million. The market capitalization would have been even much lesser if not for the meteoric rise of Global Testing share price lately. The total number of outstanding shares stood at just 35 million and 45% of the stakes are held by Yageo Corp, Mr Chia Soon Loi (Non-Executive Chairman of Global Testing) and Mr Chen Tie-Min (Chairman of Yageo Corp).

LIFETIME MEMBERSHIP The on-going Ukraine crisis has sent global stock markets into a devastating tailspin. The war occurs at a very bad timing as global economy is in the midst of recovering from the protracted pandemic. In this context, how will Healthway Medical share price unravel in 2022? A concerned Lifetime member has written in to enquire the lack of vitality for this counter.

Due to the request from a Lifetime Member, I am writing this article to provide my insights on Healthway Medical share price. Apart from the request, I have been wanting to cover this counter for some time because of my recent annual body check-up at one of Healthway Medical clinics.

For background, Healthway Medical is a private outpatient medical service provider operating more than 100 clinics and medical centres in Singapore. Within Singapore, Raffles Medical is a competitor of Healthway Medical. The difference between the two is that the former is listed in SGX Mainboard while the latter is listed in Catalist.

On 25 February, the Group announced a set of stellar financial result yet Healthway Medical share price remained moribund. Why is this so? Average 3-month trading volume amounted to just 19.75 million while 5-year Beta was 0.58.

LIFETIME MEMBERSHIP What a bombshell revelation. On 23 February 2022, OCBC share price got ripped apart after the bank released its FY2021 financial result. It was supposed to be the day that investors pop the champagne. Instead, investors were horrified to see OCBC share price plunging by as much as 6% on that fateful day.

To rub salt into injury, OCBC share price bucked the trend of DBS and UOB shares, which increased on 23 February. This was the first time that DBS and UOB share prices rose while OCBC share price got bombed out. For years, these three counters had always moved in tandem. Evidently, investors ran for their lives, sending OCBC share price straight to the gallows.

The subject of debate at here is: does the FY2021 result really justify the collapse of OCBC share price? Okay, the venerable bank missed the estimates of most analysts (including mine). But surely that doesn’t warrant the explosive meltdown of OCBC share price? We are talking about a financial institution that raked in higher net profit of $4.86 billion. If you claim that the bank suffered a financial loss over the year, I would have accepted the meltdown. But clearly, this is not the case.

LIFETIME MEMBERSHIP What a perfect storm for AEM share price. Investors must put on their seat belts and braced for a roller-coaster ride. Year-to-date, AEM share price tumbled 18.9% to reach the current $4.25. The collapse of AEM share price occurred right before the release of FY2021 financial result. Is this a sign of things to come for AEM share price?

Apparently, the cocktail of headwinds – the unfolding Ukraine-Russia conflict and looming interest rate hikes – had knocked the wind out of AEM’ sail. To rub salt into injury, the USD counter had received poor reception, effectively dashing hopes of a NASDAQ listing. The resulting outcome is a crisis of confidence for AEM share price.

For the past two weeks, data extracted from SGX portal showed that AEM had been on the top ten net sell institutional list. The week of 7 Feb 2022 saw the counter topping the list, with $22 million worth of shares being net sold by the big boys. It seems that big boys are fleeing the counter. This could explain the downward trend of AEM share price in recent weeks.

To be honest, it is hard to imagine Non-Executive Chairman Loke Wai San pulling another rabbit out of the hat.

LIFETIME MEMBERSHIP What an explosive form! OCBC share price went on a rampage to hit a high of $13.50 (at the point of writing). On the basis of the current run, it appears to me that OCBC share price is on course to race past its previous record of $13.70 in April 2018.

To be sure, OCBC share price has not peaked. Both DBS and UOB share prices are now trading at all-time highs after announcing stellar financial results. OCBC Bank will release its FY2021 result on 23 February 2022. Barring unforeseen circumstances, I expect the result to be stellar like DBS and UOB. Thus, OCBC share price should continue its bull run in the next couple of weeks.

The supersonic form of OCBC share price should be the work of the big boys. According to data extracted from SGX, institutional fund houses had been pouring funds into OCBC shares for the past two months. In fact, OCBC topped the list of institutional fund house net buys for five consecutive weeks! This is something unprecedented. The strong buying in from the big boys sent OCBC share price to the moon.

The presence of the big boys can be a double-edged sword.

LIFETIME MEMBERSHIP Man proposes, God disposes. This Valentine Day was supposed to be the day that DBS share price rocketed to high heavens. However, the looming Ukraine war gate-crashed to spoil the party for investors, causing Dow Jones to fall 500 points on 11 February 2022. In the aftermath, DBS share price had a minor correction. Question now is: will the full-year financial result set DBS share price on fire and brush aside the uncertainties of a potential Ukraine war?

Russia could be launching an attack on Ukraine, possibly on this Wednesday. The conflict would surely lead to massive uncertainties for the global stock market. DBS, being the leading light of SGX, would not be spared from the market carnage. Certainly, the unfolding event is bad timing for DBS share price as the bank delivered a set of stellar financial result. In this respect, investors should expect much volatility for DBS share price in the coming days.

It remains to be seen if the Ukraine-Russia conflict could really escalate to a war, so it is still premature to claim that it is the end of the road for DBS share price. At the point of writing, it seems that the record earnings for DBS has boosted investors’ confidence, thereby providing a key support for DBS share price.

Lifetime Membership DBS will release its full-year FY2021 financial result on 14 February 2022, before the market opens. When a listed company releases its financial result before market opens, it usually means one thing – the result should be good. In this regard, investors should expect plenty of fireworks for DBS share price.

DBS share price has been on a solid bull run for the past few weeks that not even the MAS’ regulatory action on its digital disruption in November 2021 could derail its bullish form. Year-to-date, DBS share had increased 13.6% to $37.25. With the stellar full-year financial result, it is not inconceivable that DBS share price would hit $50 in the coming weeks.

It has not been a bed of rose for investors as DBS share price had previously endured a torrid run in late 2021 following market’s reaction to a subpar 9MFY2021. Omicron had emerged out of nowhere to create much uncertainties for DBS share price. And with the occurrence of the online disruptions, we have the perfect storm for DBS share price.

Then again, no winter lasts forever. For DBS share price, this is no exception. Investors were relieved that MAS’ regulatory action requires DBS to set aside additional capital amounting to $930 million.